33 results
10-Q
2023 Q1
GNLX
Genelux Corp
15 May 23
Quarterly report
12:00am
the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we … injury or is found to be otherwise unsuitable during clinical testing, manufacturing, marketing or sale. Any such product liability claims may include
10-K
8bbq5d7xujtlbcmx82j9
29 Mar 23
Annual report
5:12pm
S-1/A
wfr0xh 4q
29 Aug 22
IPO registration (amended)
4:01pm
S-1
EX-10.17
ofo3xfmw
24 Jun 22
IPO registration
4:35pm
S-1
EX-10.18
gtyuzkl2uf9lx9ryn
24 Jun 22
IPO registration
4:35pm
S-1
EX-10.13
pieku725g8bw
24 Jun 22
IPO registration
4:35pm
S-1
EX-10.16
rfcni0
24 Jun 22
IPO registration
4:35pm
S-1
jbzuk2laebdyep kj
24 Jun 22
IPO registration
4:35pm
S-1
EX-10.14
ajyad1hbg45j1ycvr0
24 Jun 22
IPO registration
4:35pm
S-1
EX-10.12
0k2iq 00mrv
24 Jun 22
IPO registration
4:35pm
S-1
EX-10.19
3v1yifk
24 Jun 22
IPO registration
4:35pm
DRS/A
w661oq kkz7s
20 May 22
Draft registration statement (amended)
12:00am